Imaging :: CT imaging with use of novel contrast agent may predict heart attack in waiting
A new imaging technology may hold the key to not only stopping heart attacks in their tracks but also preventing them for ever occurring.
A new imaging technology may hold the key to not only stopping heart attacks in their tracks but also preventing them for ever occurring.
Researchers at the University of Pennsylvania?s School of Medicine have discovered that implantable cardioverter-defibrillators (ICDs) — electric monitoring devices that deliver a lifesaving shock in the event of a cardiac arrest — help patients with heart problems live longer more active lives.
A new study published in the Journal of the American Medical Association found no increased risk of heart attack for women in their 50s who were taking HRT.
Dr Carmine Pariante, a psychiatrist researching into effects of stress and depression and Dr Veronica O’Keane, a perinatal psychiatrist, spoke about the biological effects of depression during a major depression conference organised by the Institute of Psychiatry this week.
The Heart and Stroke Foundation (HSF) joined Toronto Public Health to release two new reports and urge the federal government to eliminate deadly processed trans fats in our food supply.
The Robert Wood Johnson Foundation (RWJF) announced it will commit at least $500 million over the next five years to tackle one of the most urgent public health threats facing our nation: childhood obesity.
As the diagnostic capability of MRI continues to advance, and as the availability of MRI machines increases worldwide, so should the availability of implantable devices that are MRI safe. This advance is urgently needed says one executive.
As reported in the May issue of Psychological Science, men who increased over time in neuroticism died earlier, mostly from cancer and heart disease.
Each year an estimated 20 million children are born with low birth weight worldwide, more than 95% of them in developing countries.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), provides comment on a re-analysis of pooled data from both hormone therapy arms of the Women?s Health Initiative (WHI) Study published in the Journal of the American Medical Association.